Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

HIV prevention

Hodgson TA, Meiners M (1979) Guidelines for Cost-of-Illness studies in the public health services. Task force on Cost-of-Illness studies, US Public Health Services, WA Holtgrave DR, Pinkerton SD (1997) Updates of Cost-of-lllness and quality of hfe estimates for use in economic evaluations of HIV prevention programs, J Acquit Immune Defic Syndr Hum Retrovirol 16 54-62... [Pg.372]

HIV-1 integrase strand transfer inhibitors, 45, 263 HIV prevention strategies, 40, 277 HIV protease inhibitors, 26,141 29, 123 HIV reverse transcriptase inhibitors, 29,123 HIV therapeutics, 40, 291 HIV vaccine, 27, 255... [Pg.569]

Prevention of HIV transmission is a major worldwide concern. A recent recommendation by the International Working Group on Vaginal Microbiocides states [34] that .. . It is desirable that an agent be evaluated for activity against HIV and other STD regardless of its intended HIV indication since a clinical outcome of HIV prevention may be achieved by the prevention... [Pg.224]

Farrell M, Gowing L, Marsden J et al. (2005). Effectiveness of drug dependence treatment in HIV prevention. International Journal of Drug Policy, 16, supp 161-15... [Pg.155]

East River HIV Center Clinical Research Assistant/Data Analyst Abstracted and recorded relevant data to the HIV prevention study from patient medical records. [Pg.79]

Gallo RC. 2005. The end or the beginning of the drive to an HIV preventive vaccine a view from over 20 years. Lancet. 366 1894-1898. [Pg.198]

Stringer JS, Sinkala M, Rouse DJ, Goldenberg RL, Vermund SH. Effect of nevirapine toxicity on choice of perinatal HIV prevention strategies. Am J Public Health 2002 92(3) 365-6. [Pg.2501]

Up-to-date information on HIV prevention research and related topics, including needle exchange programs... [Pg.105]

HIV prevention in IV drug users http //www.nida.nih.gov/POHP/lndex.html... [Pg.261]

The 1986 report Confronting AIDS Direction for Public Health, Health Care, and Research was an lOM-initiated project that addressed seriously what had been to that time a largely ignored epidemic. Subsequent reports have addressed needle exchange, the behavioral and mental health aspects of HIV infection and AIDS, and the prevention of perinatal transmission of HIV. The most recent lOM report on the subject. No Time to Lose Getting More from HIV Prevention, provides a comprehensive review of current HIV-prevention efforts in the United States, as well as a framework for future activities. [Pg.481]

Sexual Health and STDs An Avenue to HIV Prevention Services." AIDS Information Exchange (U.S. Conference of Mayors) 12 6-8. [Pg.101]

Hammett, T.M., D.C. Des Jarlais, W. Liu, D. Ngu, and N. Son. 2002. "A Cross-Border HIV Prevention Intervention for Injection Drug Users (IDUs) in Ning Ming Country Guangxi Province, China and Lang Son Province, Vietnam." Paper presented at the 14th International AIDS Conference, Barcelona, Spain. [Pg.103]

Centers for Disease Control and Prevention. HIV Prevention Strategic Plan Through 2005 (www.cdc.gov/hiv/pubs/prev-strat-plan.pdf). [Pg.2274]

Malhpeddi, R., Rohan, L.C., 2010. Nanoparticle-based vaginal drug dehvery systems for HIV prevention. Expert Opin. Drug Deliv. 7 (1), 37—48. [Pg.206]

Donnell D, Baeten JM, Bumpus NN, Brantley J, Bangsberg DR, Haberer JE, Mujugira A, Mugo N, Ndase P, Hendrix C et al. (2014) HTV protective efficacy and cOTielates of tenofovir blood concentrations in a clinical trial of PrEP for HIV prevention. J Acquit Immune Defic Syndr 66 340-348... [Pg.157]

Lucas GM, Beauchamp G, Aramrattana A, Shao Y, liu W, Fu L, et al. Short-term safety of buprenorphine/naloxone in HIV-seronegative opioid-dependent Chinese and Thai drug injectors enroUed in HIV Prevention Trials Network 058. Int J Drug PoUcy March 2012 23(2) 162-5. [Pg.116]

Owino F, Mandala J, Ambia J, Agot K, Van Damme L. Neurological syndrome in an HIV-prevention trial participant randomized to daily tenofovir disoproxil fumarate (300 mg) and emtricitabine (200 mg) in Bondo, Kenya. Int Med Case Rep J 2013 29(6) 91-3. [Pg.438]

Madison, S., McKay, M., Paikoff, R., Bell, C. (2000). Basic research and community collaboration Necessary ingredients for the development of a family-based HIV prevention program. AIDS Education and Prevention, 12(4), 281-298. [Pg.177]

Stevenson, H., Davis, G., Weber, E., Wieman, D., Abdul-Kabir, S. (1995). HIV prevention beliefs among urban African American youth. Journal of Adolescent Health, 16, 316-323. [Pg.178]


See other pages where HIV prevention is mentioned: [Pg.373]    [Pg.58]    [Pg.308]    [Pg.464]    [Pg.13]    [Pg.461]    [Pg.13]    [Pg.22]    [Pg.109]    [Pg.396]    [Pg.415]    [Pg.416]    [Pg.237]    [Pg.109]    [Pg.510]    [Pg.513]    [Pg.47]    [Pg.68]    [Pg.68]    [Pg.23]    [Pg.195]    [Pg.128]    [Pg.173]   
See also in sourсe #XX -- [ Pg.68 ]




SEARCH



HIV prevention strategies

© 2024 chempedia.info